Gadavist 10 mmol/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FUQGZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,304
Award facts
- Contract value 100% obligated
- $3,304.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,304.18 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, due for completion on September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vehicle (SPE2DX) running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies to support Defense Health Agency operations and other government healthcare systems. This delivery order for Gadavist, a contrast agent used in medical imaging, exemplifies the company's ongoing role as a key supplier within the DLA's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DB25FUQGZ?
SPE2DB25FUQGZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FUQGZ worth?
The government has obligated $3,304 on SPE2DB25FUQGZ.
Is contract SPE2DB25FUQGZ an order under another contract?
Yes. SPE2DB25FUQGZ is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQGZ competed?
The extent of competition for SPE2DB25FUQGZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award